A phase 1 study in healthy volunteers to investigate the safety, tolerability, and pharmacokinetics of VIR-2482: a monoclonal antibody for the prevention of severe influenza A illness

This study has been registered at ClinicalTrials.gov under identifier NCT04033406.PMID:38376227 | DOI:10.1128/aac.01273-23

Source: Antimicrobial Agents and Chemotherapy - February 20, 2024 Category: Microbiology Authors: David Plotnik Jennifer E Sager Madhukar Aryal Marie C Fanget Alessia Peter Michael A Schmid Deborah Cebrik Erik Mogalian Keith Boundy Wendy W Yeh Paul Griffin Maribel Reyes Source Type: research